- Home
- IDYA vs TDC Comparison
IDYA vs TDC Comparison
Compare IDYA & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- TDC
- Stock Information
- Founded
- IDYA 2015
- TDC 1979
- Country
- IDYA United States
- TDC United States
- Employees
- IDYA N/A
- TDC N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- TDC Computer Software: Prepackaged Software
- Sector
- IDYA Health Care
- TDC Technology
- Exchange
- IDYA Nasdaq
- TDC Nasdaq
- Market Cap
- IDYA 2.3B
- TDC 2.1B
- IPO Year
- IDYA 2019
- TDC 2007
- Fundamental
- Price
- IDYA $26.88
- TDC $22.15
- Analyst Decision
- IDYA Buy
- TDC Buy
- Analyst Count
- IDYA 15
- TDC 7
- Target Price
- IDYA $47.92
- TDC $29.67
- AVG Volume (30 Days)
- IDYA 1.2M
- TDC 1.2M
- Earning Date
- IDYA 11-03-2025
- TDC 11-03-2025
- Dividend Yield
- IDYA N/A
- TDC N/A
- EPS Growth
- IDYA N/A
- TDC 79.70
- EPS
- IDYA N/A
- TDC 1.13
- Revenue
- IDYA $7,000,000.00
- TDC $1,675,000,000.00
- Revenue This Year
- IDYA $63.41
- TDC N/A
- Revenue Next Year
- IDYA $305.49
- TDC N/A
- P/E Ratio
- IDYA N/A
- TDC $19.53
- Revenue Growth
- IDYA N/A
- TDC N/A
- 52 Week Low
- IDYA $13.45
- TDC $18.43
- 52 Week High
- IDYA $32.67
- TDC $33.69
- Technical
- Relative Strength Index (RSI)
- IDYA 59.69
- TDC 52.02
- Support Level
- IDYA $26.77
- TDC $21.33
- Resistance Level
- IDYA $28.41
- TDC $23.18
- Average True Range (ATR)
- IDYA 0.92
- TDC 0.68
- MACD
- IDYA 0.04
- TDC -0.02
- Stochastic Oscillator
- IDYA 59.24
- TDC 37.04
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About TDC Teradata Corporation
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.